Great West Life Assurance CO Alaunos Therapeutics, Inc. Transaction History

Great West Life Assurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.41 - $1.24 $4,609 - $13,941	-11,243 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$2.39 - $3.43 $21,517 - $30,880	9,003 Added 401.92%	11,243 $28,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $21,517 - $30,880	-9,003 Reduced 80.08%	2,240 $5,000
Q2 2020 Aug 17, 2020	BUY	$2.2 - $3.71 $4,507 - $7,601	2,049 Added 22.29%	11,243 $37,000
Q4 2019 Feb 11, 2020	BUY	$3.95 - $5.35 $36,316 - $49,187	9,194 New	9,194 $43,000
Q3 2019 Oct 25, 2019	SELL	$4.13 - $6.94 $72,869 - $122,449	-17,644 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$4.99 - $6.57 $88,043 - $115,921	17,644	17,644 $109,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.